During the past decade, Dasman Diabetes Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dasman Diabetes Institute" #1 collaborator was "Kappa Bioscience" with 1 trials as a collaborator, "Kuwait Foundation for the Advancement of Sciences" with 1 trials as a collaborator, "University at Buffalo" with 1 trials as a collaborator and "University of Glasgow" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Dasman Diabetes Institute" are "Diabetes Mellitus, Type 2" (4 trials), "Asthma" (1 trials), "Diabete Type 2" (1 trials), "Diabetes" (1 trials) and "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials). Many other conditions were trialed in "Dasman Diabetes Institute" in a lesser frequency.

Most popular intervention types in "Dasman Diabetes Institute" are "Behavioral" (3 trials), "Other" (3 trials), "Dietary Supplement" (2 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "AphoelineBrake" (1 trials), "Exercise" (1 trials), "Face-to-face personalised advice" (1 trials), "GLP-1 receptor agonist" (1 trials) and "Home-based" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dasman Diabetes Institute" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Dasman Diabetes Institute". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dasman Diabetes Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dasman Diabetes Institute, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".